~27 spots leftby Dec 2025

Fuzzy Wale Compression Stockinet for Peripheral Arterial Disease

Recruiting in Palo Alto (17 mi)
Overseen byMatthew Melin, M.D.
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Mayo Clinic
No Placebo Group

Trial Summary

What is the purpose of this trial?The objective of this study is to determine if using Fuzzy Wale compression stockinett can assist in reducing the healing time and decrease costs in trastibial amputation patients as compared to standard of care treatment compression stocking.

Eligibility Criteria

This trial is for individuals who have had a below-the-knee amputation due to peripheral arterial disease. The study aims to include those who require post-surgical healing support.

Inclusion Criteria

I have diabetes.
Tobacco use at any time in past or current use (pack years)
Prior contralateral leg amputation
+6 more

Exclusion Criteria

Vulnerable study population
Known allergies to any of the components of the compression
Pregnancy
+4 more

Participant Groups

The trial is testing the effectiveness of a Fuzzy Wale Compression Stockinet in speeding up healing and reducing costs compared to standard compression stockings after transtibial amputation.
2Treatment groups
Experimental Treatment
Active Control
Group I: Fuzzy Wale Compression StockinetExperimental Treatment1 Intervention
Subjects with peripheral arterial disease requiring transtibial amputation will have Fuzzy Wale Compression Stockinet applied 3-7 days pre-operatively and utilized for 4-8 weeks post operatively or until prosthetic fitting and wound has achieved full durable healing.
Group II: Standard of careActive Control1 Intervention
Subjects with peripheral arterial disease requiring transtibial amputation will receive standard of care treatment compression stockinet.

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
Mayo ClinicRochester, MN
Loading ...

Who Is Running the Clinical Trial?

Mayo ClinicLead Sponsor

References